Chemical inhibitors of protein kinases

被引:295
作者
Bridges, AJ [1 ]
机构
[1] Ann Arbor Labs, Pfizer Global Res & Dev, Ann Arbor, MI 48105 USA
关键词
D O I
10.1021/cr000250y
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The role of Protein kinases as potential drug tragets was studied. The use of protein kinases for cellular signaling and cancer therapy was discussed. The chemical inhibitors of protein kinases like PKC and BCR-ABL along with epidermal growth factor receptor TK inhibitors and anilinopyrimidine inhibitors were also described.
引用
收藏
页码:2541 / 2571
页数:31
相关论文
共 259 条
[21]   Synthesis and Src kinase inhibitory activity of a series of 4-phenylamino-3-quinolinecarbonitriles [J].
Boschelli, DH ;
Wang, YD ;
Ye, F ;
Wu, BQ ;
Zhang, N ;
Dutia, M ;
Powell, DW ;
Wissner, A ;
Arndt, K ;
Weber, JM ;
Boschelli, F .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (05) :822-833
[22]  
Boschelli Diane H., 1999, Drugs of the Future, V24, P515, DOI 10.1358/dof.1999.024.05.858622
[23]   Enantioselective inhibition of the epidermal growth factor receptor tyrosine kinase by 4-(alpha-phenethylamino)quinazolines [J].
Bridges, AJ ;
Cody, DR ;
Zhou, HR ;
McMichael, A ;
Fry, DW .
BIOORGANIC & MEDICINAL CHEMISTRY, 1995, 3 (12) :1651-1656
[24]  
Bridges AJ, 1999, CURR MED CHEM, V6, P825
[25]   Tyrosine kinase inhibitors .8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor [J].
Bridges, AJ ;
Zhou, H ;
Cody, DR ;
Rewcastle, GW ;
McMichael, A ;
Showalter, HDH ;
Fry, DW ;
Kraker, AJ ;
Denny, WA .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (01) :267-276
[26]  
BRIDGES AJ, 1995, Patent No. 09519774
[27]  
BROWN DS, 1996, Patent No. 9615118
[28]  
Bruns CJ, 2000, CANCER RES, V60, P2926
[29]  
Buchdunger E, 1996, CANCER RES, V56, P100
[30]   Cell cycle molecular targets in novel anticancer drug discovery [J].
Buolamwini, JK .
CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (04) :379-392